BioCentury
ARTICLE | Company News

QLT appoints Hastings as CEO

December 19, 2001 8:00 AM UTC

QLT (QLTI; TSE:QLT), which markets its Visudyne PDT for age-related macular degeneration, appointed Paul Hastings as president, CEO and a director, effective Feb. 17. He replaces Julia Levy, who will ...